Harrow: Harrow shares react modestly to FDA move
Stock of Nashville eyecare pharmaceutical company sees value minimally changed after federal OK related to drug
Read full article »
Harrow is a Tennessee-based pharmaceutical company that researches and develops ophthalmic prescription therapies for patients.
Read more